Pharmafile Logo

Inyta

- PMLiVE

NICE backs GSK’s €594k gene therapy for rare disease

The treatment offers 'bubble baby' patients an alternative to a stem cell transplant

National Institute for Health and Care Excellence NICE logo

NICE to look again at Pfizer’s Besponsa after appeal

The blood cancer medicine was originally turned down on cost-effectiveness grounds

- PMLiVE

Novartis bags new breakthrough status for Kisqali in breast cancer

The Swiss pharma group’s treatment will rival Lilly’s Verzenio and Pfizer’s Ibrance if approved

- PMLiVE

FDA’s year-end approvals take annual tally to 46

Rhopressa and Steglatro were among the final medicines licensed last year

Are you providing the kind of content that affiliates want? 5 questions to answer.

To ensure that your content gets used by local markets and has a real impact, consider these questions when commissioning core materials.

Anthill Agency

How to provide affiliate-friendly content

To ensure that your core content gets used by affiliates, empowerment is key. Here are two simple strategies to achieve it.

Anthill Agency

Novartis day

Novartis’ Extavia evades NICE restrictions on MS drugs

But Avonex, Plegridy, Betaferon, Rebif and Copaxone are set to be turned down

Patient involvement in health technology assessment

Patients can improve the quality, relevance and value of HTA for all pharma stakeholders

The kind of data that affiliates want

The right kind of data builds affiliate support for international digital marketing.

Anthill Agency

The big dilemma in international digital pharma marketing

How to get consistent international marketing while meeting local affiliates’ needs.

Anthill Agency

Pfizer names Albert Bourla as COO

John Young and Angela Hwang also take up new positions at the pharma firm

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links